Pursuant to the Company’s Code of Conduct for Prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, Ortin Global has informed that the trading window for dealing in the securities of the Company will remain closed from 01.01.2025 till 48 hours after the declaration of un-audited financial results of the company for the Quarter ended on 31-12-2024, for all designated persons, their immediate relatives and all connected persons covered under the Company’s Code of Conduct. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for considering the said financial results for the third quarter ended on 31st December, 2024, shall be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: